Jun 13 2012
Fluidigm (NASDAQ:FLDM) today unveiled the details of its new C1™ 
      Single-Cell AutoPrep System to attendees at the International Society 
      for Stem Cell Research (ISSCR) meeting in Yokohama, Japan. The C1 
      System, based on Fluidigm's innovative microfluidic technology, enables 
      a researcher to isolate and process individual cells rapidly and 
      reliably for genomic analysis. For the first time, a researcher can 
      isolate cells, extract RNA, and then reverse transcribe and preamplify 
      mRNA transcripts automatically to enable detection and analysis of cell 
      activity.
    
    
      Fluidigm has become a leader in the emerging field of single-cell 
      genomics with its widely adopted BioMark™ and BioMark HD Systems, 
      enabling scientists to routinely examine previously unavailable genomic 
      signatures generated from a single cell. The stem cell research 
      community in Japan, and indeed around the world, has been an important 
      early customer group exploring single cells. Stem cell, cancer and 
      immunology research are expected to be the initial focus applications 
      for the C1 System.
    
    
      As part of its activities at ISSCR, Fluidigm also announced the start of 
      its Early Access Program for the C1 System. The C1 
      System has been specifically designed to work seamlessly with the 
      BioMark HD System to enhance the workflow and reliability of data for 
      scientists studying single-cell genomics. The Early Access Program 
      allows select customers the opportunity to receive the first commercial 
      shipments during the second half of 2012 before shipment to the broader 
      group of customers. In addition to being the first to utilize the new 
      technology, Early Access Program partners will be provided with no-cost 
      startup consumables, participate in the development of new platform 
      capabilities, and receive pre-market access to future platform 
      expansions. Researchers interested in the Early Access Program can 
      register at www.fluidigm.com/c1system.
    
    
      "The new C1 Single-Cell AutoPrep System is the first of its 
      kind. The C1 System handles, separates and prepares 
      individual single cells for genetic analysis. We are very excited about 
      the commercial release of the C1, for we believe it will 
      enable single-cell research on a broad scale that will in turn make 
      profound contributions to numerous fields in biology," said Gajus 
      Worthington, President and Chief Executive Officer, Fluidigm. "Though 
      the C1 represents a major advance in single-cell genomics, we 
      are at the beginning of what we can do together with the scientific 
      community. Ultimately, the C1 System will allow researchers 
      to study cell differentiation, measure individual cell responses to 
      specific stimuli, verify critical disease biomarkers, validate RNAi 
      knockdown, and sequence individual cells," Worthington concluded.
    
    
      The C1 System workflow is initiated by loading a sample of 
      cells in solution into the C1 microfluidic chip in a single 
      pipetting step, then directing the C1 System to rapidly and 
      automatically isolate up to 96 individual cells into individual chambers 
      for preparation. After loading, researchers can choose an "in-process" 
      quality control checkpoint to verify the number of captured cells and 
      distinguish live from dead cells to preserve data integrity. The 
      workflow then proceeds with a rapid "on-chip" cell lysis without RNA 
      purification, reverse transcription, and preamplification without 
      hands-on reagent mixing and sample transfer. The final preamplified cDNA 
      product is thereafter harvested to collection wells for transfer to the 
      BioMark HD System for quantitative PCR analysis.
    
    
      The C1 Single Cell AutoPrep System consists of:
    
    
      - 
        C1 Single-Cell AutoPrep System that provides breakthrough 
        bench-top automation of isolation, lysis and preamplification 
        performed on single cells.
      
 
      - 
        C1 Single-Cell AutoPrep Array chip that facilitates capture 
        and highly paralleled preparation of up to 96 individual cells.
      
 
      - 
        C1 Single-Cell AutoPrep Reagent Kit, a pre-formulated 
        "ready to use" reagent kit that supports cell suspension, lysis and 
        purification.
      
 
    
    
Source: Fluidigm Corporation.